Human Immunodeficiency Virus type 1 Endocytic Trafficking Through Macrophage Bridging Conduits Facilitates Spread of Infection
- First Online:
- Cite this article as:
- Kadiu, I. & Gendelman, H.E. J Neuroimmune Pharmacol (2011) 6: 658. doi:10.1007/s11481-011-9298-z
- 1.1k Downloads
Bridging conduits (BC) sustain communication and homeostasis between distant tethered cells. These are also exploited commonly for direct cell-to-cell transfer of microbial agents. Conduits efficiently spread infection, effectively, at speeds faster than fluid phase exchange while shielding the microbe against otherwise effective humoral immunity. Our laboratory has sought to uncover the mechanism(s) for these events for human immunodeficiency virus type one (HIV-1) infection. Indeed, in our prior works HIV-1 Env and Gag antigen and fluorescent virus tracking were shown sequestered into endoplasmic reticulum-Golgi organelles but the outcomes for spreading viral infection remained poorly defined. Herein, we show that HIV-1 specifically traffics through endocytic compartments contained within BC and directing such macrophage-to-macrophage viral transfers. Following clathrin-dependent viral entry, HIV-1 constituents bypass degradation by differential sorting from early to Rab11+ recycling endosomes and multivesicular bodies. Virus-containing endocytic viral cargoes propelled by myosin II through BC spread to neighboring uninfected cells. Disruption of endosomal motility with cytochalasin D, nocodasole and blebbistatin diminish intercellular viral spread. These data lead us to propose that HIV-1 hijacks macrophage endocytic and cytoskeletal machineries for high-speed cell-to-cell spread.
KeywordsHIV-1 Macrophage Bridging conduits Tunneling nanotubes Recycling endosomes Multivesicular bodies Viral trafficking Endocytic sorting Lysosomes Early endosomes Motor proteins Tubulin Intercellular viral spread
Retroviruses exploit subcellular structures to facilitate infection and evade immune surveillance. One of these is bridging conduits (BC), also referred to as tunneling nanotubes, that serve to tether distant cells (Gerdes et al. 2007; Xu et al. 2009). For mononuclear phagocytes (MP; monocytes, macrophages and dendritic cells) such conduits serve as cytoplasmic extensions that facilitate open-ended bidirectional exchange of cellular organelles and proteins amongst cells (Kadiu and Gendelman 2011). They also affect intercellular communication and can facilitate microbial infections (Chinnery et al. 2008; Onfelt et al. 2006; Xu et al. 2009; Kadiu and Gendelman 2011). The human immunodeficiency virus type one (HIV-1) may exploit such high-speed intercellular conduit communication links to accelerate spread of infection in lymphoid and neural tissues. Persistent viral replication would then ensue even during robust humoral immune responses (Gousset et al. 2009; Sowinski et al. 2008). HIV-1 Env, Gag, and Nef were identified in BC (Eugenin et al. 2009a, b; Sowinski et al. 2008; Xu et al. 2009). However, it remained unclear whether these represent mature HIV-1 surfing on the conduits or viral particulates sequestered into endocytic compartments (Eugenin et al. 2009a, b; Xu et al. 2009). More importantly, whether HIV-1’s presence in BC facilitates infection or if the virus also engages in receptor-mediated “surfing” of conduits as seen for herpes simplex and murine leukemia viruses (HSV and MLV) (Dixit et al. 2008; Sherer et al. 2007) is not known. As for the latter, HSV and MLV bind to cell surface receptors then travel to neighboring cells where fusion-dependent entry ensues. Here, lateral movement of the lipid bilayer coupled with internal actin retrograde flow facilitates intercellular viral transfers (Sherer and Mothes 2008). HIV-1 may also be sequestered into endosomes then travel in BC for intercellular spread. Recent evidence supports BC endocytic transport of HIV-1 and other pathogens. This is as follows. First, transfer of prions through conduits occurs within lysosomes (Gousset et al. 2009). Second, for HIV-1, it exploits endosome-BC trafficking pathways for its own sustenance. Viral assembly and budding occurs in intracellular vacuoles, late endosomes and multivesicular bodies (MVB) (Deneka et al. 2007; Orenstein et al. 1988). Macrophage endocytic compartments, such as late endosomes and MVB harbor infectious virus (Pelchen-Matthews et al. 2003; Sharova et al. 2005). Third, macrophage not T cell conduits support open-ended bidirectional exchange of endolysosomal compartments between tethered cells (Sowinski et al. 2008; Onfelt et al. 2006). Although HIV-1-macrophage interactions were extensively investigated, the endocytic entry route for HIV-1 transfer was considered non-productive (Miyauchi et al. 2009; Uchil and Mothes 2009). The ability of macrophages to establish BC in vivo at times of robust antiretroviral immune responses is important as the process could be exploited to accelerate viral spread (Ciborowski and Gendelman 2006; Eilbott et al. 1989; Xu et al. 2009).
In attempts to better understand how HIV-1 may use BC for its spread, we studied the mechanism of intercellular viral transfer. Our prior works investigated trafficking through ER and Golgi networks. This was found necessary for HIV-1 cell-to-cell transfer but the pathways and regulatory processes remained ill defined (Kadiu and Gendelman 2011). Thus to this end, we used proteomic, immunologic and cell imaging assays to now demonstrate that HIV-1 is sequestered into clathrin-coated pits then sorted from early endosomes into non-degrading compartments. This included, but was not limited to, Rab11 recycling endosomes and MVB. Actomyosin networks regulated BC compartment mobility. The process occured 25 times faster than those recorded for “surfing” of retroviruses on filopodia (Sherer et al. 2007). Endosomes carry viral cargoes capable of viral gene expression. These data provide novel mechanisms of HIV-1 spread seen during host immune responses and show pivotal insights into what need be overcome in realizing an effective vaccine for viral elimination.
Antibodies (Abs) and reagents
Rabbit Ab to myosin II, charged MVB protein 4a (CHMP4a) and goat Ab to Rab11 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Human Ab to Gag (recognizes GagPr55, p24, p17, matrix), gp120, gp160, reverse transcriptase (RT), protease, integrase and the TZM-bl cell line were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH (Bethesda, MD). Rabbit Abs to a- and β-tubulin and lysosome associated membrane protein 1 (LAMP1), as well as mouse and sheep Abs to HIV-1 gp120 were purchased from Novus Biologicals, LLC (Littleton, CO). Mouse Ab to LAMP1, early endosome antigen (EEA1), HIV-1 p24 and human leukocyte antigen (HLA-DR) and poly-D-lysine/fibronectin-coated LabTek chamber slides were purchased from BD Biosciences (San Diego, CA). Rabbit Abs to EEA1 and clathrin were purchased from Cell Signaling Technologies (Danvers, MA). Rabbit anti-mouse and mouse anti-goat secondary Abs conjugated to 6 nm gold particles were purchased from Electron Microscopy Sciences (Hatfield, PA). The following reagents were purchased from Invitrogen (Carlsbad, CA): beta-galactosidase (ß-gal) staining kit, Click-iT RNA Alexa Fluor 594 Imaging Kit, fluorescence in-situ hybridization (FISH) Tag RNA multicolor kit, rhodamine phalloidin, phalloidin Alexa Fluor 488 and 647, transferrin (Tfn) conjugated to Alexa Fluor 594, anti-rabbit Alexa Fluor 488, 594,647, anti-mouse Alexa Fluor 488, 594, 647, anti-sheep Alexa Fluor 488, anti-human Alexa Fluor 488, 1,1’dioctadecyl-3, 3,3’,3’-tetramethylindodicarbocyanine perchlorate (DiD), 3,3’dioctadecyloxacarbocyanine perchlorate (DiO), ProLong Gold anti-fading solution with 4′,6-diamidino-2-phenylindole (DAPI). Dulbecco’s Modified Medium (DMEM) high glucose with GlutaMax, Dulbecco’s Phosphate Buffer Saline (DPBS), Penicillin/Streptomycin were purchased from Gibco/Invitrogen (Carlsbad, CA). Wortmannin, brefeldin A (BFA), blebbistatin (BBST), cytochalasin D (CD), nocodasole (Noc), dynasore, dithiothreitol (DTT), 3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate (CHAPS), urea, thiourea, bovine serum albumin (BSA), triton-X and protease inhibitor cocktail were purchased from Sigma-Aldrich (Saint Louis, MO). COBAS Amplicor HIV-1 Monitor Test, v 1.5 was purchased from Roche Diagnostics Systems, Inc (Brunchburg, NJ).
HIV-1 infection of human monocyte-derived macrophages (MDM)
Experiments with human peripheral blood mononuclear cells (PBMC) were performed in full compliance of the National Institutes of Health and the University of Nebraska Medical Center ethical guidelines. Monocytes from HIV-1, HIV-2 and hepatitis seronegative human donors were obtained by leukophoresis, and purified by countercurrent centrifugal elutriation (Gendelman et al. 1988). Experiments were performed utilizing primary human monocytes (N = 50 independent cultures). Monocytes were grown in suspension cultures using Teflon flasks. Cells were cultured in DMEM supplemented with 10% heat-inactivated human serum, 100 units of penicillin and 100 μg/ml of streptomycin, and 1,000 U/ml highly purified recombinant macrophage colony stimulating factor (MCSF), a generous gift by Pfizer, Inc., (Cambridge, MA). Cells were maintained at 37°C in a 5% CO2 atm for 7 d to permit for differentiation into MDM. At day 7, MDM were exposed to the macrophage-tropic strain HIV-1ADA at a multiplicity of infection (MOI) of 0.5 infectious viral particles/cell for 24 h. Prior to seeding in mixed cultures (infected and uninfected MDM), HIV-1 infection was assessed by flow cytometry analysis of cells stained for HIV-1 p24 FITC (Kadiu et al. 2007).
Virus isolation and labeling techniques
Virus isolation was performed as described (Kadiu et al. 2007). Enriched HIV-1 was labeled with 2 μM DiO or DiD for 20 min in phosphate buffered saline (PBS) at 37°C. Virus was resuspended in PBS and centrifuged twice at 100,000 × g on a 20% sucrose cushion to remove unbound dye. For intercellular tracking of virus, labeled HIV-1 was resuspended in culture medium and added to adherent MDM in mixed culture prior to time-lapse microscopy.
Time-lapse confocal imaging
MDM grown in suspension were labeled with 2 μM DiD (infected) and DiO (uninfected) for 20 min at 37°C in 5% CO2. Unbound dyes were removed by washing three times with DMEM supplemented with 10% heat-inactivated human serum at 37°C. Cells were seeded on 35-mm glass-bottom plates (MatTek Corporation, Ashland, MA) in mixed cultures and subjected to live imaging at 37°C and 5% CO2. Images were taken in 5 s time intervals, using a 100× oil immersion objective attached to a Nikon TE2000-U utilizing a Swept Field Confocal microscope (Nikon, Tallahassee, FL). Brightness and contrast of the movies were adjusted to improve visibility of particles associated with BC. Imaging of particle movement in BC (from cell body to cell body) was performed manually using the NSI Elements software (Nikon). Particles with trajectories shorter than 10 frames and moving out of focus during recording were excluded from the tracking analysis.
Fluorescence in-situ hybridization
Alexa Fluor 488-labeled linearized Gag-Pol probes (2.2 kb; Hind III-Kpn; Lofstrand Labs Limited, Gaithersburg, MD) were generated using FISH Tag RNA Multicolor Labeling Kit (Invitrogen). Probe labeling and in-situ hybridization were performed per manufacturer’s instructions.
HIV-1 endocytic entry and intracellular trafficking
Adherent MDM were washed three times and incubated with serum free medium for 30 min. Cells were incubated for 30 min with either 100 μM of dynasore in serum-free medium or left untreated. Cells were washed once with serum-free media, then DiD-labeled HIV-1 together with fresh inhibitors was added to MDM for 3 h at 37°C. Cells were washed three times in PBS, mechanically detached using cell lifters (Thermo-Fisher Scientific, Waltham, MA), fixed in 4% paraformaldehyde (PFA) for 30 min and analyzed for viral uptake by flow cytometry. Data was acquired on a FACSCalibur flow cytometer (BD Biosciences) using CellQuest Software (BD Biosciences). For disruption of endocytic sorting, MDM were plated for 3 h in mixed culture, followed by treatment with 1 mM wortmannin and 0.5 mM BFA for 3 h. Cells were washed three times with PBS and fixed with 4% PFA for 30 min. Immunostaining and confocal analyses followed as described below.
Disruption of HIV-1 transport
For disruption of endosome motility, uninfected and HIV-1-infected MDM were labeled with DiO (as described above) and plated in mixed culture for 3 h to allow for contact establishment. Cells were exposed to DiD-labeled virus for 1 h and then treated with 50 μM CD, Noc, or BBST for 10 min. Inhibitors were removed, and BC-dependent cell-to-cell endosome transfer was determined by time-lapse confocal microscopy and particle tracking analyses. A group of inhibitor-treated and untreated unlabeled cells in mixed culture were stained for HIV-1 Env and Gag and myosin II and imaged by confocal microscopy.
Imaging of recycling compartments
MDM in mixed culture were seeded onto poly-D-Lysine-coated chamber slides for 3 h devoid of human serum. Cells were incubated with 1 μM Alexa 594-Tfn or DiO-labeled HIV-1 for 1 h. Non-internalized particulates were removed by three sequential washes with PBS. Cells were fixed with 4% PFA and imaged using the 63× oil lens of a LSM 510 confocal microscope (Carl Zeiss MicroImaging, LLC, Thornwood, NY).
Metabolic labeling of RNA and proteins
Metabolic labeling and detection of newly synthesized RNA was performed using Click-It RNA labeling kit per manufacturer’s instructions (Invitrogen). Metabolic incorporation of 5-ethynyl uridine (EU) was extended to 24 h. Additional immunostaining and imaging of the MDM was performed as described below.
Immunocytochemistry and confocal microscopy
For immunofluorescence staining, cells were washed three times with PBS and fixed with 4% PFA at room temperature for 30 min. Cells were treated with blocking/permeabilizing solution (0.1% Triton, 5% BSA in PBS) and quenched with 50 mM NH4Cl for 15 min. Cells were washed once with 0.1% Triton in PBS and sequentially incubated with primary and secondary Ab at room temperature. For MDM stained with multiple antibodies, non-specific cross binding of secondary Abs was tested prior to immunostaining. Use of secondary antibodies originating or recognizing the same hosts was avoided. Slides were covered in ProLong Gold anti-fading reagent with DAPI and imaged using a 63X oil lens in a LSM 510 confocal microscope (Zeiss).
Enrichment of macrophage protrusions and proteomic characterization
Enrichment of the macrophage protrusions was performed as described with some modifications (Beckner et al. 2005). Prior to BC collection, cells were maintained in Teflon flasks and media was changed every 2 d to maintain the infected MDM cultures metabolically stable. Cells were then seeded on a 9 mm thick, 3-μm pore polycarbonate filter of a Boyden chemotaxis apparatus (NeuroProbe, Gaithersburg, MD) and maintained at 37°C in a 5% CO2 tissue culture incubator for 3 h. Prior to harvesting of BC, each filter was first immersed in 100% methanol for 15 s then placed with migrated cell materials (attached to the undersurface of the filter) on a glass slide. Each filter was firmly pressed against a glass slide to promote adherence of migrated cellular processes. Cell bodies were wiped from the filter top, and the filter was then gently peeled off the slide with forceps. The processes were solubilized in lysis buffer pH 8.5 [30 mM Tris HCl, 7M urea, 2M thiourea, 4% (w/v) CHAPS, 20 mM DTT and 1X protease inhibitor cocktail by pipeting. The remainder of the lysate was allowed to crystallize on slides and harvested using razor blades. One-dimensional gel electrophoresis, mass spectrometry and database searches were performed as described (Kadiu et al. 2009).
Scanning and transmission electron microscopy
MDM were seeded in mixed culture on Thermanox coverslips (Thermo-Fisher Scientific) and allowed to establish BC for 24 h. Cells were then washed with PBS and fixed in 2% glutaraldehyde and 2% PFA in 0.1M Sorensen’s phosphate buffer (SPB). Post-fixation cells were exposed to 1% osmium tetraoxide for 30 min and dehydrated at 50%, 70%, 90%, 95%, and 100% ethanol for 10 min. Samples for transmission electron microscopy (TEM) were embedded in Araldite. Coverslips were removed and areas of the cell culture were selected for ultrathin (60 nm thick) sectioning. Cells were sectioned on the plane of the colony and in cross sections. Sections were stained with uranyl acetate and lead citrate and observed in a Tecnai G2 Spirit TEM (FEI Company, Hillsboro, OR). Samples for scanning electron microscopy (SEM) were critical point dried, mounted on specimen stubs and sputter coated with 40 nm of gold/palladium. Samples were observed with FEI Quanta 200 SEM (FEI Company) operated at 25 kV. For immunogold labeling, MDM in mixed infected and uninfected cultures were fixed with 2% glutaraldehyde and 2% PFA in 0.1M SPB for 24 h. Cells were washed in PBS and permeabilized with 0.5% Triton-X and 3% BSA in PBS for 24 h then incubated with primary Ab for 4 h at ambient temperature. Between incubation with gold conjugated Ab (6 nm) for 2 h, MDM were washed three times in 0.5% Triton-X and 3% BSA. Cells were then post-fixed with 2% glutaraldehyde and 2% PFA in 0.1M SPB and processed for TEM as described above.
Enrichment of endocytic compartments
Immune isolation of endocytic compartments was performed as previously described, with some modifications (Basyuk et al. 2003). MDM (400 × 106 cells) were seeded in mixed cultures (uninfected and infected MDM at equal ratios) and allowed to establish BC for 24 h (>90% of cell population connected by BC). Cells were scraped in homogenization buffer (10 mM HEPES-KOH, pH 7.2, 250 mM sucrose, 1 mM EDTA, and 1 mM Mg(OAc)2) and disrupted by 15 strokes in a dounce homogenizer. Nuclei and unbroken cells were removed by centrifugation at 800 × g for 15 min at 4°C. Supernatant was layered on a 20% sucrose cushion and centrifuged at 100,000 × g for 1 h. The pellet was resuspended in 40% sucrose, 10 mM imidazole solution pH 7.4 followed by layering on 60%, 35%, 20% and 10% sucrose gradient and centrifugation at 100,000 × g at 4°C for 1 h. The interfaces between 10% and 20% and 40% and 35% sucrose bands containing enriched endocytic compartments were collected and washed in PBS using ultracentrifugation at 100,000 × g. Pellets were then incubated with protein A/G paramagnetic beads (20 μl of slurry; Millipore) previously conjugated to endosome Ab (10 μg of Ab) for 12 h at 4°C. Endocytic compartments were washed and collected on a magnetic separator (Invitrogen). For TEM imaging endocytic compartments were fixed in 2% glutaraldehyde and 2% PFA in 0.1M SPB for 3 h and then isolated by magnetic separation. The bead-endosome pellet was then covered in agar and processed for TEM as described above.
Reporter cell line
TZM-bl cells were cultured in DMEM supplemented with 10% fetal bovine serum, 100 units of penicillin and 100 μg/ml of streptomycin. Cells were allowed to reach 70% confluence, then detached by 25 mM trypsin/EDTA for 5 min at 37°C. Detached cells were cultured and allowed to recover in 4 well poly-D-lysine LabTech chamber slides for 2 d or until they reached 40% confluence. Protein A/G paramagnetic beads bound to isotype control Abs or endocytic compartments (20 μl of slurry/500 μl of medium/well), and HIV-1 Tat protein (2 μM) were reconstituted in supplemented DMEM and added to cells. Replicate wells were pre-treated with 100 μM Efavirenz (EFZ) for 24 h prior to exposure to endocytic compartments. Chamber slides were placed on a plate magnet (Oz Biosciences/Boca Scientific, Boca Raton, FL) for 24 h at 37°C in 5% CO2 after addition of endocytic compartment-bead conjugates. The magnet was removed and cells were washed three times with PBS and maintained in culture medium for additional 48 h prior to β-gal detection (per manufacturer’s instructions). Bright field images were acquired using a Nikon Eclipse TE300 microscope (Nikon).
Quantitation of endosome viral load
RNA viral load for EEA1+, Rab11+, CHMP4+ and LAMP1+ immune-isolated compartments was measured using COBAS Amplicor HIV-1 Monitor Test, v 1.5 and COBAS AmpliPrep Instrument for automated specimen processing (Roche Diagnostics) per manufacturer’s instructions.
Colocalization tests and statistical analyses
Quantitation of immunostaining and Pearson’s colocalization coefficients was performed with ImageJ software, utilizing JACoP plugins (http://rsb.info.nih.gov/ij/plugins/track/jacop.html) (Bolte and Cordelieres 2006). Comparison was performed on 7–10 sets of images (whole cells) acquired with the same optical settings. To improve visibility of subcellular compartments in the BC, brightness and contrast settings were changed for the entire image in select images using Adobe Photoshop. Graphs and statistical analyses were generated using Excel and GraphPad Prism. Two-tailed Student’s t-tests were used for all data and the error bars are shown as ± S.E.M., unless noted otherwise. Results were considered significant at P < 0.05.
BC speeds communication between MDM
HIV-1 constituents in BC
HIV-1 is sequestered into endosomes
Characterization of the BC endocytic transport machinery
We next sought to identify the intercellular transport compartments for HIV-1. To this end, we characterized the proteome of the macrophage conduits. To mimic formation of BC in mixed cultures, HIV-1-infected MDM were seeded on a filter membrane separating them from the lower chamber of a Boyden chemotaxis apparatus containing uninfected MDM-conditioned medium (Fig. S3A–B). Figure 3e shows infected MDM extending their processes through filter pores unto the lower chamber (arrows). Protrusions were mechanically detached from the cell bodies and visualized by bright field and confocal microscopy (Fig. S3C, D). Proteomic characterization of enriched conduits identified early, late and recycling endosomes, MVB, lysosomes and actin-binding proteins. Regulators of endocytic sorting, including Rab GTP-ases (Rab1, 2, 5, 7a, 11a) and late endosome-lysosomal markers (annexin II and IV, MHCI, MHCII, as well as ubiquitin and cathepsin isoforms) (Jouve et al. 2007; Zerial and McBride 2001) accounted for 13% of the conduit proteome (Fig. 3f; Table S2). Proteins driving endosome movement and regulators of actin stress fibers such as myosin motor proteins IC, II, light chain (LC) 6 and heavy chain (HC) 9, together with other actin-binding proteins represented 14% of the overall proteome, while HIV-1 proteins accounted for 4%. These findings indicated that active endocytic transport of HIV-1 occurred in the macrophage conduits.
Endosomes, HIV-1 and BC
Intra- and intercellular trafficking of HIV-1 constituents in MVB-Rab11 recycling endosomes
Having identified Env, Gag and RNA in several endosome populations and their preferential distribution with recycling endosomes, we next queried whether HIV-1 sorting routes converged with the recycling pathway. Endosomes and lysosomes may undergo partial fusion with late and recycling endosomes to form temporary recycling hybrid compartments targeted for the plasma membrane (Blott and Griffiths 2002; Bright et al. 1997; Luzio et al. 2005). This process would explain the overlap in endocytic distribution of HIV-1. Indeed, partial colocalization of EEA1 (54 ± 2%), LAMP1 (34 ± 1%) and CHMP4a (34 ± 2%; mean ± S.E.M., n = 80 cells/group) was observed with Rab11+ compartments. In addition, endosomes carrying both early endosome and MVB markers were also identified (Figure S5A–C). Disruption of MVB biogenesis using wortmannin (Gruenberg and Stenmark 2004) and endocytic recycling with BFA (Wang et al. 2001) caused aggregation of Gag in large perinuclear vacuoles and excluded Gag from the BC (Figure S5D, E). Collectively, these findings demonstrate that dissemination of HIV-1 constituents through the conduits occurs within endosomes and is regulated primarily by the MVB-Rab11a recycling route.
Endocytic compartments carry infectious virus
Next, we determined the viral load (HIV-1 RNA copies) in each isolated endosome population. COBAS Amplicor analysis showed endosomes carried high viral loads (∼104 HIV-1 RNA copies/μg of Ab; Fig. 5c). Numbers of HIV-1 RNA copies were distinct for each endosome population (Fig. 5c). Rab11 endosomes displayed the highest viral load (3.2 × 104 RNA copies/μg of Ab) further supporting the role of the recycling pathway in viral trafficking. HIV-1 viral load for the isotype control pool was at background level, thus excluding non-specific binding to other virus-containing membranes. To establish infectivity of endocytic viral cargo, we used a TZM-bl reporter cell line, which contains an integrated copy of the ß-gal gene under control of the HIV-1 promoter (Platt et al. 1998). In MDM connected by BC, we and others have observed a seamless flow of endosomes between infected (DiO-labeled) and uninfected cells (DiD-labeled cells; Fig. S6A, B) (Onfelt et al. 2006). Upon reaching the target cells, endosomes either preserve their characteristics or fuse with native endosomes (encircled yellow). To test infectivity of endocytic cargoes, we mimicked direct access of endosomes to the intracellular milieu of the target cells. To accomplish this, we considered the following limitations: First, the TZM-bl reporter cell line has limited phagocytic characteristics and the immune isolated endosomes do not carry surface molecules (i.e., Fc receptors) necessary for internalization. Therefore, this excluded the possibility of receptor-mediated endocytosis as a mode of introducing the isolated compartments to the intracellular environment of TZM-bl. Second, isolated endosomes remain attached to the bulky magnetic beads (10–15 μm in diameter) that constituted a large cell entry barrier. Therefore, to gain access into the cytoplasm of the target cells (as it would occur via open-ended BC), endosome-bead complexes were forced into the TZM-bl by exposure to strong magnetic fields (Fig. 5a). Integration and expression of viral genome were confirmed by ß-gal detection (blue) at 72 h post-exposure (Fig. 5d,e). Cells exposed to Rab11a and CHMP4a endosomes induced similar levels of ß-gal as those observed with cell-free HIV-1 (P > 0.05). The infectivity of early endosomes and lysosomes was measured at significantly lower levels than cell-free HIV-1 (P < 0.001, Fig. 5g). Since, HIV-1 Tat+ compartments were identified in the BC, we questioned whether the expression of ß-gal could be induced by Tat alone. TZM-bl were exposed to 2 μM recombinant Tat for 24 h and then stained for ß-gal. Tat treatment altered the cellular morphology of TZM-bl compared to untreated uninfected cells; however similar to control exposure, Tat alone did not induce ß-gal expression (Fig. 5d). Pre-treatment of TZM-bl with EFZ (a non-nucleoside reverse transcriptase inhibitor) prior to endosome exposure significantly (P < 0.0001) reduced ß-gal expression (Fig. 5f,g). These findings indicate infectious viral cargoes are preserved within endosomes and are capable of inducing bona fide infections.
HIV-1 is transported through the BC in non-degrading endocytic compartments
Next, we examined the role of endosome transport in viral propagation. MDM labeled with DiD were exposed to fluorescently labeled HIV-1 and allowed to establish viral transfer through the conduits to the uninfected cells (Movie S6). Alternatively, cells exposed to DiO-HIV-1 were treated with CD, Noc and BBST. CD and Noc were tested for inhibition of endocytic transport due to involvement of actin tails and microtubules in the propulsion of endosomes (DePina and Langford 1999).
We demonstrated that unlike other retroviruses that “surf” cellular protrusions, HIV-1 exploits endocytic traffic through bridging conduits for its intercellular spread. In previous studies, viral endocytic entry was shown to effect the viral life cycle (Martin and Sattentau 2009; Uchil and Mothes 2009). HIV-1 enters the cell by clathrin-mediated endocytosis and uncoating, occurs in endocytic compartments (Miyauchi et al. 2009). Indeed, genomic screens for host proteins required for infection demonstrate a dependency of HIV-1 replication on the integrity of the endocytic networks (Brass et al. 2008). HIV-1 intracellular endocytic trafficking is linked to viral assembly and budding. The latter occurs within the MVB and in the endoplasmic reticulum and Golgi membranes (Orenstein et al. 1988; Pelchen-Matthews et al. 2003). Although endolysosomal compartments are in BC, specific endocytic pathways and endosome sub-types used for intra- and intercellular viral processing remained unknown (Rustom et al. 2004; Uchil and Mothes 2009) until now.
What targets viral constituents to a neighboring cell requires further investigation. Previous studies demonstrated the presence of antigen-presenting MHCII-CD4 complexes and HIV-1 proteins in BC formed between macrophages, B cells and T cells in lymph nodes (Brown et al. 2008; Chinnery et al. 2008; Xu et al. 2009). Proteomic and confocal analyses also identified these proteins in the macrophage BC. Since HLA-DR is the most abundant protein in the HIV-1 Env, it is likely that processing of HIV-1 may be guided by CD4-HLA-DR endocytic processing (Callahan et al. 1993; Ott et al. 2000). This could explain similarities in HLA-DR processing routes and trafficking of viral constituents within MVB recycling compartments (Fernandes et al. 2000; Raposo et al. 2002; Romagnoli et al. 1993). These processes may be relevant for viral spread in vivo. HIV-1 may exploit the high mobility and antigen presentation characteristics of macrophages as a “Trojan Horse” for immune escape and dissemination.
Equally important issues remain; such as, can infectious virus be transmitted ell-to-cell from within endocytic compartments and does this mode of viral transfer result in the productive infection? MVB are likely infectious (Pelchen-Matthews et al. 2003). Our works demonstrate that in addition to MVB, which may carry HIV-1, early and recycling endosomes and lysosomes also transmit viral RNA and proteins. Regardless of abundant presence of HIV-1 constituents and RNA within endosomes, we were unable to identify mature HIV-1 within BC and immune isolated endosomes. Mature HIV-1 was frequently observed in the extracellular space. Instead, high-density endocytic compartments were easily identified and those carrying capsid-like structures were rarely observed. Although we performed extensive TEM analysis, we do not exclude the possibility that BC endocytic compartments could also carry mature HIV-1. However, there was a discrepancy between the viral loads and infectivity of endocytic compartments as well as our inabilities to observe mature virus by ultrastructural tests. We posit that a potential alternate route of HIV-1 dissemination and productive infection through the conduits could exist. This would involve sequestration of HIV-1 in endocytic compartments followed by uncoating and content mixing (Miyauchi et al. 2009). These viral cargoes would then be shuttled to uninfected target cells where viral components, although disassembled, could be capable of initiating infection.
If this were the case, then how is viral material unloaded from the endosomes to the cytosol of target cells? Recent studies on the MLV replication cycle have shown that Rab11 endosomes carrying MLV RNA have the ability to fuse with or bud from the cytosol either to release RNA in proximity to the nucleus or transport newly synthesized viral RNA to the plasma membrane (Basyuk et al. 2003). Similar to MLV, our data show that HIV-1 and cellular RNA primarily traffick within and between cells by Rab11 recycling endosomes. This would also explain how viral material gains access to effector cell endosomes and to target cell cytosol via BC. In addition to the relay of viral constituents by direct endosome-endosome fusion (clathrin pits-early endosomes-early endosomes-recycling endosomes or MVB-recycling endosomes), it is likely that budding and fusion of Rab11 with the cytosol allow loading of newly synthesized and original viral constituents into endosomes along with subsequent unloading into uninfected cells via BC-mediated transport. This process may be facilitated by seamless flow of endocytic compartments between BC-connected cells. Indeed, we observed that upon reaching the target cells, endosome transport was not interrupted and these compartments either fused with autochthonous endocytic compartments or preserved their original membranes. Additionally, connected polarized cells were observed to share organelles such as ER and Golgi (our unpublished observations). Formation of a cellular network that precedes and can lead to syncytium formation may allow the connected cells to function as a unicellular organism (Kadiu et al. 2007). Therefore, processes of viral assembly, maturation, release (in the effecter cell) as well as entry, and disassembly (in the target cells) are voided, thus reducing both transfer time and exposure to the host immune system (Martin and Sattentau 2009). Nonetheless, the infectivity of disassembled virus has not been previously reported. Processing of viral constituents into overlapping, yet different sorting routes suggests such a mode of viral transfer may exist and represents a barrier in designing efficient and targeted therapeutic strategies against HIV-1 infection.
Alternatively, HIV-1 may be trafficked from cell to cell within endosomes. We posit that four potential mechanisms may account for intercellular transfer of virus. First, MDM become productively infected, and newly synthesized virus gains access to intracellular membranes of neighboring cells where they are assembled and then transported to uninfected cells. This is however not very likely to occur since metabolic tracing of newly synthesized HIV-1 Env and Gag revealed targeting of these proteins to the plasma membrane rather than the conduits (our unpublished observations). Second, HIV-1 could be internalized by a polarized macrophage during secondary infection or “superninfection”. Internalized virus may be then directly “recycled” to adjacent cells. Third, macrophages could “archive” mature HIV-1 progeny in endocytic compartments and upon contact, transfer HIV-1-containing compartments through BC to uninfected cells. Fourth, although HIV-1 was distributed primarily with non-degrading compartments, we cannot exclude the possibility that transfer of HIV-1 to the uninfected cell may be driven by apoptosis of the effecter cells. Natural killer cells use conduits as a means for transfer of apoptotic bodies from dying cells (Chauveau et al. 2010). A similar process may occur in macrophages, as a function of their phagocytic and debris clearing activities. Although, low levels of cell death were measured in polarized MDM mixed cultures (our unpublished observations), uninfected MDM were often observed to form contacts with multinucleated giant cells. Therefore it is likely that endocytosed HIV-1 or progeny assembling in intracellular membranes during the initial stages of cell death may exploit transport of apoptotic bodies through the conduits as a means of survival. We posit that transmission of replication competent virus and transfer of viral constituents could occur in tandem. The processes that drive HIV-1 intercellular transfer by direct cell–cell contact nonetheless requires further investigation. Whether or not alternative transfer of viral constituents facilitate the viral life cycle or perhaps incite infection remains an open question.
We thank Drs. R. L. Mosley, H. S. Fox and R. Taylor for the critical reading of the manuscript. We would like to acknowledge Dr. F. Kieken, F. Robert for bioinformatics support; T. Bargar, J. Taylor for their assistance with electron and confocal microscopy, B. Wassom for graphic design of the elements in Figure S8. This work was supported in part by National Institutes of Health grants P20 DA026146, 5P01 DA028555-02, R01 NS36126, P01 NS31492, 2R01 NS034239, P20 RR15635, P01 MH64570, and P01 NS43985 (to H.E.G). The authors declare no competing financial interests.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Intra- and intercellular trafficking of fluorescently-labeled HIV-1 in MDM. Uninfected MDM were seeded in adherence and then stained with DiO (green). Cells were exposed to DiD-labeled HIV-1 (red). Cells were imaged every 5 s over an interval of 3 min. The movie is played in tandem for each fluorophore at a speed of 15 frames/s (scale bar, 10 μm). (MOV 1789 kb)